ENTITY

Pacific Edge (PEB NZ)

51

Analysis

Health Care • New Zealand

Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.

more

Refresh

Focused

bullish•Pacific Edge

•02 Jun 2022 08:22•Broker

Pacific Edge (PEB): FY22 Result – Initial Impressions

Pacific Edge (PEB)FY22 Result – Initial Impressions Pacific Edge (PEB) reported a FY22 result slightly below our expectations with revenue...

Forsyth Barr

698 Views

Share

bullish•Pacific Edge

•04 Apr 2022 08:01•Broker

Pacific Edge: Sticking to the Script

Pacific EdgeSticking to the Script OUTPERFORM Pacific Edge's (PEB) share price is down -30% year to date, we view this as unjustified. While we...

Forsyth Barr

21 Views

Share

bullish•Sky Network Television

•27 Dec 2021 08:19•Broker

Morning News Summary: BoE Hikes, ECB Continues QE — Stocks Like It

Morning News SummaryBoE Hikes, ECB Continues QE — Stocks Like It Equity markets traded mixed on Thursday after three major central banks pulled...

Forsyth Barr

1.4k Views

Share

bullish•Pacific Edge

•03 Dec 2021 08:02•Broker

Pacific Edge: 1H22 Result — Edging Ahead

Pacific Edge1H22 Result — Edging Ahead OUTPERFORM Pacific Edge (PEB) reported a 1H22 result broadly in-line with expectations with lower than...

Forsyth Barr

1.1k Views

Share

bullish•Pacific Edge

•02 Dec 2021 08:40•Broker

Pacific Edge (PEB): 1H22 Result – Initial Impressions

Pacific Edge (PEB)1H22 Result – Initial Impressions Pacific Edge (PEB) reported a 1H22 NPAT loss of -NZ$9.0m, which was +NZ$0.4m better than our...

Forsyth Barr

1k Views

Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9

x